baber/WOPTO huggingface dataset:
Patent CA-3113739-A1 (CA)
Inventor: CURTIS STEVE
IPC: G16H50/30
Filed: 2019-09-21
Abstract: L'invention concerne un système et un procédé de distribution de revenus à des utilisateurs sur la base de données émotionnelles quantifiées et qualifiées des utilisateurs. Le procédé comprend les étapes consistant à : recueillir et recevoir des données biorythmiques de l'utilisateur; analyser les données biorythmiques et calculer et suivre un score émotionnel; envoyer une recommandation à des utilisateurs potentiels pour effectuer des actions se rapportant à une plateforme et des produits; calculer un sous-score total individuel pour chaque utilisateur à l'aide des données émotionnelles quantifiées et qualifiées sur un intervalle de temps; calculer un ou plusieurs scores de sous-total sur la base de calculs effectués sur les recommandations et des recommandations associées correspondant à chaque utilisateur; calculer les scores de sous-total de chaque utilisateur sur la base de données de l'utilisateur individuel sur la plateforme; combiner le score de sous-total individuel et le score de sous-total pour obtenir un score unique pour chaque utilisateur; générer des revenus lorsque les utilisateurs potentiels réalisent des actions se rapportant à la plateforme et au produit et distribuent une quantité prédéfinie d'argent à chaque utilisateur.
Patent CA-3114285-A1 (CA)
Inventor: MERRITT BEN
IPC: A61B17/221
Filed: 2019-08-08
Abstract: Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, positioning a distal portion of a catheter proximate to the clot material within the blood vessel. The method can further include coupling a pressure source to the catheter via a tubing subsystem including a valve or other fluid control device and, while the valve is closed, activating the pressure source to charge a vacuum. The valve can then be opened to apply the vacuum to the catheter to thereby aspirate at least a portion of the clot material from the blood vessel and into the catheter.
Patent CA-3114743-A1 (CA)
Title: Hot-rolled and annealed ferritic stainless steel sheet and method for producing the same
Inventor: YOSHINO MASATAKA
IPC: C22C38/50
Filed: 2019-09-25
Abstract: The present invention provides: a ferrite stainless hot-rolled-and-annealed steel sheet that is excellent for punching, has substantial corrosion resistance, and makes it possible to achieve a prescribed dimensional precision without cracking when punched into a thick flange; and a production method for the ferrite stainless hot-rolled-and-annealed steel sheet. A ferrite stainless hot-rolled-and-annealed steel sheet that has a ferrite single phase structure that has a component composition that contains, by mass%, 0.001%0.020% of C, 0.05%1.00% of Si, 0.05%1.00% of Mn, no more than 0.04% of P, no more than 0.01% of S, 0.01%0.10% of Al, 10.0%20.0% of Cr, 0.50%2.00% of Ni, 0.10%0.40% of Ti, and 0.001%0.020% of N, the remainder being Fe and unavoidable impurities, the average crystal grain size of the metal structure of the ferrite single phase structure being 520 µm.
Patent CA-3115707-A1 (CA)
Inventor: BAKER MARK R
IPC: A62D1/00
Filed: 2019-10-11
Abstract: L'invention concerne un fluide aqueux pour tête d'extincteur contenant un sel de carboxylate en C4 ou en position supérieure permettant d'abaisser le point de congélation. Les sels peuvent être utilisés conjointement avec des glycols. Les sels réduisent la combustibilité de fluides et donnent une plus faible viscosité que celle de fluides à plus forte teneur en glycol, ces deux propriétés offrant des avantages pour des systèmes têtes d'extincteurs. Ces solutions de sels ne sont pas agressives pour des canalisations en métal et en CPVC et sont donc utiles pour des systèmes têtes d'extincteurs en ce qu'elles ne provoquent pas de craquelures sous l'effet de contraintes prolongées des composants en CPVC et en ce qu'elles ne sont pas corrosives pour les pièces métalliques.
Patent CA-3116221-A1 (CA)
Inventor: RHYSING DARYIAN
IPC: H01B13/012
Filed: 2019-10-13
Abstract: A apparatus for monitoring the integrity of an electrical wire includes a clamp system, a sensor system, a user interface configured to receive input data and output wire information, and a control unit configured to process the wire data, process the input data, and generate the output wire information. The clamp system includes a clamp and the sensor system includes a sensor configured to retrieve the wire data. In another embodiment, a portable device is configured to obtain wire data from a smart clamping system, to transmit the wire data to a processor and to receive a multi-dimensional representation, and a computer system configured to receive the wire data generated and to generate the multi-dimensional representation of the wire. A method for monitoring a wire includes capturing wire data using a clamp, transmitting the wire data to a control unit, generating wire information to output, and outputting the wire information.
Patent CA-3116510-A1 (CA)
Title: Fire starting strip
Inventor: SNELL SIMON GEORGE
IPC: C10L11/06
Filed: 2021-04-28
Abstract: A fire starting strip 10 for igniting a bed of charcoal or for lighting a log fire, without the need for any one or more of: kindling, lighter fluid or newspaper, the fire starting strip 10 comprising an elongate body 12 which is covered or impregnated with fuel, the elongate body 12 having a length substantially in the range of 15 to 100 cm and being substantially at least five times longer than it is wide.
Patent CA-3117417-A1 (CA)
Title: Minimisation d'artefact de neurostimulation
Inventor: SINGLE PETER SCOTT VALLACK
IPC: A61N1/36
Filed: 2019-10-23
Abstract: La présente invention concerne un dispositif de neurostimulation comportant un stimulus, et une position d'une électrode de mesure par rapport au stimulus, conçue de telle sorte que, dans un artefact tel qu'il se produit quant à la distance par rapport à l'électrode de stimulus, une région minimale de l'artéfact soit sensiblement colocalisée avec l'électrode de mesure. Ou alors, un rapport de l'espacement inter-électrodes à la longueur d'électrode est compris entre 2 et 3,66. Ou alors, une impédance est connectée à une électrode passive et est conçue pour réduire un artefact survenant sur l'électrode de mesure. FIG. 23a : AA%%% Dispositif de commande de boucle SCS BB%%%Cible CC%%%Dispositif de commande de boucle d'artefact DD%%%Dispositif de commande de source de courant EE%%%Détecteur d'énergie CA FF%%%Détecteur ECAP GG%%%Réseau d'électrodes
Patent CA-3117460-A1 (CA)
Inventor: EVERTS JORDI
IPC: H02M1/42
Filed: 2019-10-31
Abstract: L'invention concerne un convertisseur électrique (10) servant à convertir une entrée en CA triphasé en une sortie en CC, comprenant trois bornes d'entrée de phase (A, B, C) et deux bornes de sortie (P, N), un sélecteur de phase (11) servant à connecter l'entrée en CA triphasé disposée au niveau des trois bornes d'entrée de phase à un nud intermédiaire supérieur (x), à un nud intermédiaire inférieur (y) et à un nud intermédiaire central (z), le sélecteur de phase comprenant des premiers commutateurs à semi-conducteur (Saza, Sbzb, Sczc) qui peuvent être commutés de manière active pour connecter sélectivement le nud intermédiaire central aux trois bornes d'entrée de phase, et un organe de commande (40). Le convertisseur électrique comprend un circuit survolteur (19, 20) et un circuit dévolteur-survolteur (14). Le circuit survolteur comprend un circuit survolteur supérieur (19), un circuit survolteur inférieur (20) et un nud commun (m) entre les deux. Le circuit dévolteur-survolteur comporte une sortie connectée aux deux bornes de sortie (P, N) en parallèle avec une sortie du circuit survolteur, le circuit dévolteur-survolteur comprenant au moins deux seconds commutateurs à semi-conducteur (SPz, SzN) qui peuvent être commutés de manière active et qui sont connectés en série entre les bornes de sortie (P, N). Le nud intermédiaire central (z) est connecté à un nud commun (t) desdits deux seconds commutateurs à semi-conducteur. Les commutateurs à semi-conducteur du circuit survolteur et du circuit dévolteur-survolteur sont commandés par des organes de commande de courant.
Patent CA-3117583-A1 (CA)
Inventor: KOHLER RICHARD E
IPC: B08B3/10
Filed: 2019-10-15
Abstract: L'invention concerne un système (10) de lavage à pression d'écoulement dirigée pour le nettoyage de précision de pièces. Le système (10) comprend une pluralité d'entrées (18) reliées à un tube de tuyau allongé (16) au niveau d'une extrémité proximale (20) correspondante par l'intermédiaire d'un raccord en t d'entrée (22). La pluralité d'entrées (18) sont conçues pour recevoir au moins un gaz (24), un détergent ou un tensioactif (26) et un solvant (28), par intermittence ou simultanément à travers celles-ci. Une source de gaz (241) fournit du gaz (24) relié à l'une de la pluralité d'entrées (18) par l'intermédiaire d'un premier tube (30). Une source de détergent ou de tensioactif (261) fournit un détergent ou un tensioactif (26) relié à l'une de la pluralité d'entrées (18) par l'intermédiaire d'un deuxième tube (32). Une source de solvant (28) fournit du solvant (28) relié à l'une de la pluralité d'entrées (18) par l'intermédiaire d'un troisième tube (34). Un dispositif de retenue d'éléments (36) est fixé de manière amovible à un tube de tuyau allongé (16) au niveau d'une extrémité distale (38) correspondante. Un tube de tuyau allongé (16) contient des pièces en son sein, de telle sorte que des pièces sont soumises à une pression dirigée variable et à un débit variable de gaz (24), de détergent ou de tensioactif (26) et de solvant (28). Le dispositif de retenue d'éléments (36) comprend des ouvertures (40) au niveau d'une sortie (42) correspondante pour permettre le passage de particules (44) à travers celles-ci tout en retenant des pièces dans le tube de tuyau allongé (16) pendant le nettoyage. L'invention concerne en outre un procédé et un appareil (12) pour le nettoyage de précision de pièces.
Patent CA-3120227-A1 (CA)
Title: Method for determining a progressive lens and associated system
Inventor: TRANVOUEZ-BERNARDIN DELPHINE
IPC: G02C7/06
Filed: 2019-11-27
Abstract: A method for determining a design of a progressive lens intended to be worn by a future wearer, the progressive lens comprising a front surface and a back surface, at least one of the front surface and the back surface comprising a progression profile on its general spherical shape, said at least one progression profile defining a meridian line extending from a distance-vision point to a near-vision point, said meridian line comprising a vertical portion passing through the distance-vision point and an inclined portion passing through the near-vision point, the vertical portion and the inclined portion forming an angle between them, the method comprising:  obtaining first data representative of a first measurement of a first postural instability of the future wearer when seeing at a visual pattern moving along an anterior-posterior direction;  determining the angle of the inclined portion based on the first data.
Patent CA-3121184-A1 (CA)
Inventor: CHASE THOMAS N
IPC: A61K31/198
Filed: 2019-09-24
Abstract: La présente invention concerne une combinaison pharmaceutique comprenant un inhibiteur des effets secondaires agonistes de la dopamine et un agoniste de la dopamine, pour traiter la maladie de Parkinson et les troubles liés à la maladie de Parkinson.
Patent CA-3121952-A1 (CA)
Title: Macrocyclic compound and use thereof
Inventor: MATSUMOTO SHIGEMITSU
IPC: A61P1/16
Filed: 2019-12-04
Abstract: A compound represented by the following formula (I): wherein each symbol in the formula is as described herein or a salt thereof has an NRF2 activating activity, and is expected to be useful as a preventive or therapeutic agent for diseases associated with oxidative stress, in particular, hepatic disease (for example, non-alcoholic steatohepatitis (NASH)), cardiovascular disease (for example, heart failure or pulmonary arterial hypertension), lung disease (for example, chronic obstructive pulmonary disease (COPD)), kidney disease (for example, chronic kidney disease (CKD) or acute kidney injury (AKI)), central nervous system disease (for example, Parkinson's disease), mitochondrial disease (for example, Friedreich motor ataxia, mitochondrial myopathy), inflammatory disease (for example, multiple sclerosis (MS), inflammatory bowel disease (IBD)), sickle cell disease, cancer, or the like.
Patent CA-3124348-A1 (CA)
Title: Defect repair using additive manufacturing
Inventor: MA NING
IPC: B23P6/04
Filed: 2020-01-10
Abstract: A method for repairing defects on a structure is disclosed herein. The method comprises use of an additive manufacturing head to inject a flowable filler material into the defect. In certain embodiments, the additive manufacturing head can be a laser metal deposition (LMD) head comprising a powder nozzle and a laser. The structure can be, e.g., a pipeline or a pressure vessel used in petroleum, petrochemical, or natural gas applications.
Patent CA-3124578-A1 (CA)
Inventor: HENRY SEBASTIEN
IPC: A61M37/00
Filed: 2014-09-30
Abstract: Embodiments of the present application provide a microneedle patch for administration of a substance of interest into a biological tissue, the patch comprising: a base substrate having a microneedle side and an opposing back side; one or more solid microneedles extending from the microneedle side of the base substrate, wherein the one or more solid microneedles comprise a substance of interest; and a mechanical force indicator configured to provide an audible, tactile, or visual signal when a force applied to the patch by a user, in the course of applying the patch to a biological tissue to insert the one or more microneedles into the biological tissue, meets or exceeds a predetermined threshold, wherein the mechanical force indicator is in line with and generally centered about the microneedles on the opposing back side of the base substrate.
Patent CA-3124835-A1 (CA)
Title: Systems and methods for supporting utility poles
Inventor: ANDERSON STEVEN PAUL
IPC: E04H12/22
Filed: 2021-07-14
Abstract: A pole support system provides temporary support to a utility pole and comprises: a bracing element positioned adjacent to, and elongated in the direction of elongation of, the utility pole and securable to the utility pole; a ballast support frame comprising a base, positionable at a location spaced horizontally apart from the utility pole; mass positionable on, and removable from, the base of the ballast support frame; and a support system comprising one or more arms extending between the bracing element and the ballast support frame.
Patent CA-3125997-A1 (CA)
Title: Systems, devices and methods for securing non-load bearing walls
Inventor: BRIGHAM GUEARY ANDREW
IPC: F16B25/00
Filed: 2021-07-21
Abstract: Disclosed are systems, devices and methods used in construction to secure one component, such as a header, to another component, such as a joist, while controlling spacing. Fasteners are used with a removable sleeve member having longitudinal ribs to secure the fastening assembly and prevent movement. An installation guide is provided that facilitates both flush and offset installation.
Patent CA-3128416-A1 (CA)
Title: Composes cycliques aromatiques ou cycliques heteroaromatiques, procede de preparation correspondant et utilisation medicale associee
Inventor: YIN HUIJUN
IPC: C07D417/14
Filed: 2020-01-17
Abstract: La présente invention concerne des composés cycliques aromatiques ou cycliques hétéroaromatiques, un procédé de préparation correspondant et une utilisation médicale associée. En particulier, la présente invention concerne un composé représenté par la formule générale (I), un procédé de préparation de celui-ci, une composition pharmaceutique le comprenant, et une utilisation de celui-ci en tant qu'agoniste du récepteur de farnésoïde X (FXR). Le composé et la composition pharmaceutique le comprenant peuvent être utilisés pour traiter et/ou prévenir des maladies liées à l'activité de FXR, par exemple, des symptômes cholestatiques, le diabète et ses complications, la stéatose hépatique non alcoolique (NAFLD), la stéatohépatite non alcoolique (SHNA), l'obésité ou un syndrome métabolique (maladies associées à la dyslipidémie, diabète, indice de poids corporel anormalement élevé), des maladies cardiovasculaires, etc. La définition de chaque substituant dans la formule générale (I) est identique à celle donnée dans la description.
Patent CA-3129100-A1 (CA)
Title: Treatment involving car-engineered t cells and cytokines
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2020-02-06
Abstract: The present disclosure relates to methods and agents for enhancing the effect of T cells engineered to express chimeric antigen receptors (CARs). These methods and agents are, in particular, useful for the treatment of diseases characterized by diseased cells expressing an antigen the CAR is directed to. Specifically, the present disclosure relates to methods comprising providing to a subject T cells genetically modified to express a chimeric antigen receptor (CAR) and administering to the subject IL2 or a polynucleotide encoding IL2. The methods of the disclosure may comprise administering IL2 or a polynucleotide encoding IL2 and a further cytokine or a polynucleotide encoding a further cytokine, wherein the further cytokine may be IL7 or IL21. The T cells genetically modified to express a CAR may be provided to the subject by administering the T cells genetically modified to express a CAR or by generating the T cells genetically modified to express a CAR in the subject. The methods of the disclosure may further comprise administering to the subject an antigen or a variant thereof, or a polynucleotide encoding an antigen or a variant thereof, wherein the T cells genetically modified to express a CAR are targeted to the antigen. In one particularly preferred embodiment, the polynucleotides administered according to the present disclosure are RNA.
Patent CA-3130628-A1 (CA)
Title: Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disorders
Inventor: LOEW ANDREAS
IPC: C07K16/28
Filed: 2020-02-21
Abstract: Multifunctional molecules that include i) an antigen binding domain that binds to a TCR variable beta chain (TCRBV) antigen; and one, two or all of: (ii) an immune cell engager (e.g., chosen from an NK cell engager, a T cell engager, a B cell engager, a dendritic cell engager, or a macrophage cell engager); (iii) a cytokine molecule or cytokine inhibitor molecule; and/or (iv) a death receptor signal enhancer. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, and methods of treating autoimmune diseases using the aforesaid molecules.
Patent CA-3131672-A1 (CA)
Inventor: TAKATANI Shinsuke
IPC: H02K1/18
Filed: 2019-12-17
Abstract: The present invention provides a rotating electrical machine using a laminated core in which electrical steel sheets following punching are adhered together with high adhesive strength. Specifically provided is a laminated core comprising a plurality of electrical steel sheets that are laminated together and have both sides coated with an insulating coating, and adhesion sections that are disposed between electrical steel sheets adjacent in the lamination direction and adhere together the electrical steel sheets, wherein all of the groups of electrical steel sheets adjacent in the lamination direction are adhered by an adhesion section, the adhesion sections are provided at a plurality sites between the electrical steel sheets, and the adhesion sections are each a layer formed from an adhesive which contains one or both from among an acrylic resin and an epoxy resin and has an SP value of 7.8-10.7 (cal/cm3)1/2.
Patent CA-3132508-A1 (CA)
Inventor: KARCHE NAVNATH POPAT
IPC: A61P31/12
Filed: 2020-03-21
Abstract: Disclosed are the macrocyclic compounds having the general Formula (I) and their tautomeric forms, stereoisomers, pharmaceutically acceptable salts, and their combination with suitable medicament, corresponding processes for the synthesis and pharmaceutical compositions and uses of compounds disclosed herein.
Patent CA-3133426-A1 (CA)
Inventor: AHMADI SEYED MOHAMMAD
IPC: A61F2/90
Filed: 2019-10-15
Abstract: An implant for in-vivo implantation which comprises an assembly of two or more constructive elements (3,4) which are movable relative to each other. Each constructive element (3,4) is partly or completely porous and comprises a porous part (5,6) with a matrix (7,8) of open cells (51,61). A first matrix (7) of the first element (3) comprises a first overlapping part (50) with a form-closed connection to a second overlapping part (60) of a second matrix (8) of the second of the constructive elements (4) through which the first overlapping part extends. The overlapping parts (50,60) are movable relative to each other to change a combined shape of the overlapping parts.
Patent CA-3134218-A1 (CA)
Inventor: FINCK WILLIAM
IPC: B62D65/08
Filed: 2015-05-20
Abstract: A glazing panel removal device comprising a winder unit having first and second winder spools for winding a cutting filament and a drive, for driving the winder spools. The drive means includes a single or common drive input for driving both the first and second winder spools. The drive maybe a rotary input drive, and driving the rotary input in a first rotary direction may cause winding of the filament onto the first winder spool and driving the rotary input in the opposite direction causes winding of the filament onto the second winder spool.
Patent CA-3134480-A1 (CA)
Inventor: AYYALA RAMESH S
IPC: A61K47/69
Filed: 2019-03-28
Abstract: Compositions of hyaluronic acid (HA) conjugated with antibiotics are disclosed for a rapid release antibiotic delivery system into a closed space to achieve rapid therapeutic range within 24 hours and effective elimination of the antibiotic within 80-120 hours. In particular, this invention is directed to compositions, method of preparation, and method of treatment to prevent invention using porous and non-porous embodiments of hyaluronic acid polymer conjugated with antibiotics or other therapeutic agents for rapid therapeutic delivery and controlled reduction of therapeutic dosages of antibiotics to prevent invention and reduce antibiotic resistance. Low concentration of crosslinkers conjugated with HA as well as using porogens and functional group modifiers allow other therapeutic to be conjugated to HA such as sugars and steroids. Suspension of HA conjugates in chitosan enable additional treatment means. Anti-cancer therapeutic agents may also be conjugated for controlled release using this system.
Patent CA-3134859-A1 (CA)
Inventor: CROSER ANGUS
IPC: A01M25/00
Filed: 2020-03-27
Abstract: A bait dispensing station including a cavity for holding a pellet of bait. The cavity can be enclosed preventing external access to the pellet. The statin also includes a compartment for holding a plurality of pellets and a means of dispensing a pellet into the cavity. A new pellet can only be dispensed into the cavity when no pellets are in the cavity. The cavity incudes a sensor to determine if there is a pallet in the cavity. The dispensing station includes a light sensor that controls access to the cavity and wherein access to the cavity is enabled essentially at night.